Mersana Therapeutics

MRSN67

Penny Stock

$2.57arrow_drop_down1.71%-$0.04

Penny Stock

MRSN67

$2.57

arrow_drop_down1.71%-$0.04

Penny Stock

Performance History

Key Stats
Open	$2.65
Prev. Close	$2.20
EPS	-0.85
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$334.90M
PE Ratio	-

	LOW	HIGH
Day Range	2.30	2.81
52 Week Range	1.06	6.28

Ratios







EPS	-0.85

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc (MRSN) is a clinical-stage biopharmaceutical company focused on developing innovative antibody drug conjugates (ADCs) for the treatment of cancer. The company's proprietary technology platform, Fleximer, allows for the creation of ADCs with enhanced potency and greater tolerability, offering the potential for improved therapeutic outcomes. Mersana's lead product candidate, XMT-1536, is currently in phase 1 clinical trials for the treatment of ovarian and non-small cell lung cancer.

Mersana Therapeutics Inc's stock price history shows a significant increase in value over the past year. In January 2020, the stock was trading around $4 per share and has since climbed to over $20 per share as of October 2021. This impressive growth is attributed to positive clinical trial results and strong investor optimism surrounding the potential of Mersana's ADC platform.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Anna Protopapas M.B.A.
Headquarters: Cambridge
Employees: 228
Exchange: NASDAQ

Keep an eye on Mersana Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Mersana Therapeutics 's (MRSN) price per share?

The current price per share for Mersana Therapeutics (MRSN) is $2.58. The stock has seen a price change of -$0.04 recently, indicating a -1.71% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Mersana Therapeutics (MRSN)?

For Mersana Therapeutics (MRSN), the 52-week high is $6.28, which is 143.88% from the current price. The 52-week low is $1.06, the current price is 141.78% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Mersana Therapeutics (MRSN) a growth stock?

Mersana Therapeutics (MRSN) has shown an average price growth of -3.55% over the past three years. It has received a score of 39 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mersana Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Mersana Therapeutics (MRSN) stock price performance year to date (YTD)?

As of the latest data, Mersana Therapeutics (MRSN) has a year-to-date price change of 13.44%. Over the past month, the stock has experienced a price change of 25%. Over the last three months, the change has been 90.74%. Over the past six months, the figure is -1.72%. Looking at a longer horizon, the five-year price change stands at -7.37%.

help

Is Mersana Therapeutics (MRSN) a profitable company?

Mersana Therapeutics (MRSN) has a net income of -$171.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.11K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $36.86M, with a revenue growth rate of 38.65%, providing insight into the company's sales performance and growth. The gross profit is $35.34M. Operating income is noted at -$170.96M. Furthermore, the EBITDA is -$101.41M.

help

What is the market capitalization of Mersana Therapeutics (MRSN)?

Mersana Therapeutics (MRSN) has a market capitalization of $328.77M. The average daily trading volume is 2.67, indicating the stock's liquidity and investor engagement.